Meitar Law Offices has been recently involved in a range of complex and high-value work for large pharmaceutical and life sciences companies. Corporate transactions are at the heart of the firm’s work; prime examples being a $1.6bn merger between two pharmaceutical companies and the $300m acquisition of an early-stage life sciences company. The firm also handles intellectual property protection and management, advice on clinical trials, product liability disputes, and regulatory matters. Key advisers to entrepreneurs, start-ups, and mature companies on M&A deals, Haim Gueta and Boaz Mizrahi co-lead the practice alongside experienced litigator Ron Peleg. Technology and IP partner Rebecca Fisher also stands out.
Legal 500 Editorial commentary
- Profile
Key clients
- Pfizer, Inc.
- Integra Lifesciences
- Medivators Inc.
- MediWound Ltd.
- Gamida Cell Ltd.
- Access Industries Inc.
- Ayala Pharmaceuticals, Inc
- CaribouBio, Inc.
- Corcept Therapeutics, Inc.
- Senseera Ltd.
Work highlights
- Representing Mayo Clinic in the Data agreement with Shiba medical hospital.
- Represented Innovalve Bio Medical Ltd. in an option agreement to be acquired by a leading pharmaceutical company.
- Represented Taro Pharmaceuticals in the merger with sun pharma.
Lawyers
Practice head
Haim Gueta; Boaz Mizrahi; Ron Peleg
Other key lawyers
Rebecca Fisher